<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13">
 <label>13</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hu</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>XX</given-names>
   </name>
   <name>
    <surname>He</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>F</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway</article-title>. 
  <source>Cancer Manage Res</source> (
  <year>2020</year>) 
  <volume>12</volume>:
  <page-range>3579–87</page-range>.  
  <pub-id pub-id-type="doi">10.2147/cmar.S243660</pub-id>
 </mixed-citation>
</ref>
